Related Experiment Video

Updated: Aug 11, 2026

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

Calcific aortic stenosis: medical and surgical management in the elderly

Nalini M Rajamannan1

  • 1Northwestern University Feinberg School of Medicine, 303 E. Chicago, Tarry 12-717, Chicago, IL 60611, USA. n-rajamannan@northwestern.edu

Current Treatment Options in Cardiovascular Medicine
|November 15, 2005
PubMed

Insights

Calcific aortic stenosis, a leading cause for valve replacement, is now viewed as an active process. Medical therapies may soon delay the need for surgery in affected patients.

Area of Science:

  • Cardiovascular Medicine
  • Valvular Heart Disease Research

Background:

  • Calcific aortic stenosis (CAS) is the primary reason for surgical valve replacement in the U.S.
  • Previously considered a passive degenerative condition, CAS shares risk factors with vascular disease.
  • Emerging evidence suggests CAS is an active, potentially treatable process.

Purpose of the Study:

  • To review current research on the pathophysiology of CAS.
  • To explore the potential for medical therapies to manage CAS.
  • To discuss future clinical trials investigating non-surgical treatments for CAS.

Main Methods:

  • Review of retrospective clinical studies on CAS risk factors.
  • Analysis of experimental research elucidating CAS mechanisms.
  • Examination of ongoing and planned clinical trials for medical CAS therapy.

Main Results:

  • Retrospective studies indicate shared risk factors between CAS and vascular disease.
  • Experimental data supports an active, rather than passive, disease process in CAS.
  • Future trials aim to validate medical interventions for delaying valve replacement.

Conclusions:

  • CAS is an active disease process with implications for medical intervention.
  • Medical therapy holds promise for delaying surgical valve replacement in CAS patients.
  • Further research and clinical trials are crucial for advancing CAS treatment.

More Related Videos

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat04:30

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat

Published on: February 4, 2021

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro05:47

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro

Published on: May 10, 2021

Related Concept Videos

Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...